Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIRECT

Financiado

DIabetes REsearCh on patient sTratification

The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a s... ver más

31/07/2019

SANOFIAVENTIS DEUT...

46M€

Presupuesto del proyecto: 46M€

Líder del proyecto

SANOFIAVENTIS DEUTSCHLAND GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 24 Participantes

Financiación concedida El organismo FP6 notifico la concesión del proyecto el día 2019-07-31 No tenemos la información de la convocatoria

0% 100%

24 Participantes

SANOFIAVENTIS DEUTSCHLAND GM...

Lider

CONSORCI INSTITUT D INVESTIG...

N.D. | Participante

Leiden University Medical Ce...

N.D. | Participante

UNEXE

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUIN2013-51220 EUROPEAN CONSORTIUM FOR RISK STRATIFICATION AND MANAGEMENT O... 23K€ Cerrado

IMIDIA Improving beta-cell function and identification of diagnosti... 27M€ Cerrado

PredRegNetworks Listening to Silence: The First Blood Test for Risk of Indiv... 150K€ Cerrado

DyNPI-T2D Dynamic Modeling of Non-Pharmacological Interventions for Ty... 223K€ Cerrado

Proceed Pharmacoepigenetics for precision medicine in type 2 diabete... 150K€ Cerrado

SAF2011-28502 EFECTOS METABOLICOS Y BIOQUIMICOS DE LA BETAINA SOBRE LA SEN... 46K€ Cerrado

Duración del proyecto: 89 meses Fecha Inicio: 2012-02-01
Fecha Fin: 2019-07-31

Líder del proyecto

SANOFIAVENTIS DEUTSCHLAND GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 46M€

Descripción del proyecto The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of type 2 diabetes with either existing or novel therapies.There is heterogeneity in who develops diabetes, the rate at which their subsequent diabetes progresses, how they respond to diabetes therapy and who develops micro- and macrovascular complications. In the DIRECT consortium we propose to identify biomarkers to identify subtypes with rapid diabetes development and progression and altered response to diabetes treatments, and develop and use these biomarkers in clinical trials.Two phenotyping work packages will focus on glycaemic deterioration and therapeutic response. For each, the DIRECT consortium brings considerable existing resource, which will be augmented by large-scale prospective cohort collection with intensive physiological and imaging phenotyping. Additional data will be added, such as existing studies on acute response to intravenous beta-cell secretagogues, and functional genomics on human islets, liver, muscle and adipose tissue, to maximise the power and utility of an innovative integrated biology approach. To enable computational multi-level integration across phenotypes and data types, a robust and secure data repository will be developed with strict data governance. As the ultimate aim of DIRECT is patient stratification, biomarkers arising from the discovery work will be used to design one or more prospective clinical trials. These will validate the biomarker(s) of interest, and establish utility in clinical practice and/or trial design and drug development. As a result, this consortium offers considerable potential to achieve major progress towards a personalized medicines approach to the treatment of type 2 diabetes.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores